0.91%

Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Fulgent Genetics Inc (FLGT)
Fulgent Genetics Inc (FLGT) News

FLGT Fulgent Genetics Inc

18.51

-0.08 (-0.43%)

24 Dec 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Fulgent Genetics Inc	NASDAQ:FLGT	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.08	-0.43%	18.51	18.16	18.79	18.88	18.30	18.60	213,130	22:00:00

Form 144 - Report of proposed sale of securities

03/12/2024 12:10am

Edgar (US Regulatory)

="/Images/box-unchecked.jpg" alt="Checkbox not checked">4100002/28/2022Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

Jian Xie
C/O Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte � CA � 91731

Common Stock

09/03/2024

1594

35005.79

Jian Xie
C/O Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte � CA � 91731

Common Stock

11/25/2024

689

12580.64

144: Remarks and Signature

Remarks

Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale, along with sales during the past 3 months, were made to satisfy tax withholding obligations through "sell to cover" transactions and do not represent a discretionary trade by the reporting person.

Date of Notice

12/02/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Paul Kim as Attorney-in-Fact